LACY WARE: Open Payments
NPI 1801217898 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,089 in 51 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $270 · 2025 $1,089
Food & beverage: $1,089
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 13 | $267 |
| Braeburn Inc. | 10 | $217 |
| Indivior Inc. | 5 | $145 |
| ABBVIE INC. | 10 | $141 |
| Vanda Pharmaceuticals Inc. | 3 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Orexo US, Inc. | 2 | $47 |
| Alkermes, Inc. | 1 | $34 |
| ViiV Healthcare Company | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: BRIXADI, SUBLOCADE, MAVYRET, CAPLYTA, HETLIOZ, Zubsolv, FANAPT, REXULTI.
Industry payments across KY — which companies pay providers there.
